Burton K, Calne D B
Clin Neurol Neurosurg. 1984;86(3):172-7. doi: 10.1016/0303-8467(84)90194-x.
The therapeutic use of dopamine agonists for Parkinson's disease, clinical guidelines for their introduction into antiparkinson regimens, and their range of adverse effects are reviewed. The role played by the dopaminomimetic ergots in elucidating dopamine receptor function, and laboratory methods that identify dopamine agonists, are also examined.
本文综述了多巴胺激动剂在帕金森病治疗中的应用、将其引入抗帕金森治疗方案的临床指南及其不良反应范围。还研究了拟多巴胺麦角生物碱在阐明多巴胺受体功能中所起的作用，以及鉴定多巴胺激动剂的实验室方法。
